tiprankstipranks
Trending News
More News >
Tonix Pharmaceuticals (TNXP)
:TNXP
US Market
Advertisement

Tonix Pharma (TNXP) Income Statement

Compare
4,993 Followers

Tonix Pharma Income Statement

Last quarter (Q3 2025), Tonix Pharma's total revenue was $3.29M, an increase of 16.58% from the same quarter last year. In Q3, Tonix Pharma's net income was $-32.01M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.09M$ 7.77M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 2.33M$ 3.03M$ 0.00$ 0.00$ -27.00K
Operating Expenses
$ 139.03M$ 121.41M$ 112.09M$ 92.31M$ 50.48M
Depreciation and Amortization
$ 3.42M$ 4.29M$ 1.25M$ 50.00K$ 27.00K
EBITDA
$ -74.32M$ -114.09M$ -110.84M$ -92.26M$ -50.44M
Operating Income
$ -136.70M$ -118.38M$ -112.09M$ -92.31M$ -50.51M
Other Income/Expenses
$ 6.67M$ 1.72M$ 1.87M$ 25.00K$ 48.00K
Pretax Income
$ -130.04M$ -116.66M$ -110.22M$ -92.29M$ -50.46M
Net Income
$ -130.04M$ -116.66M$ -110.22M$ -92.29M$ -50.46M
Per Share Metrics
Basic EPS
$ -176.60$ -6.37K$ -811.68$ -163.97K$ -5.06K
Diluted EPS
$ -176.60$ -6.37K$ -811.68$ -163.97K$ -5.06K
Weighted Average Shares Outstanding
2.26M 1.83M 3.07M- 2.56M
Weighted Average Shares Outstanding (Diluted)
2.26M 1.83M 3.07M- 2.56M
Currency in USD

Tonix Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis